483 Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) Nov 2011

483 Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) Nov 2011

Regina Brown FDA, Sangeeta Khurana FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) - Punjab, India facility and issued inspectional observations (via FDA 483) on 25 Nov 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Nov 2011
  • Location: Punjab, India
  • FEI: 3002807972
Add To Cart